News & Analysis - CNBC

1. Shares in Wegovy-maker Novo Nordisk pop 7% after GLP-1 pill approval

2. Trump halts wind projects, including Coastal Virginia Offshore Wind, Dominion stock drops 4%

3. Why Warner Bros. Discovery shareholders might opt for Paramount's offer — and why they might not

4. Inside the rise of Gen Z’s nostalgia-fueled plush-toy craze as they delay adulthood

5. Hanwha Ocean shares jump 10% after Trump says South Korean firm to build warships for U.S. Navy

6. FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

7. Alphabet to acquire data center and energy infrastructure company Intersect

8. Brick trophies, a life-size pink Cadillac and a team sponsorship: Why Lego is going all in on F1

9. Asia’s worst-performing currency is set for a rocky start to 2026

10. Epstein Files: Schumer to force Senate vote on suing DOJ over partial release

11. How U.S. oil tanker seizures targeting Venezuela are linked to rising geopolitical tensions with China

12. Asia-Pacific markets mostly climb after AI trade lifts Wall Street overnight

13. Crypto laments loss of key ally on Capitol Hill after Lummis announces retirement

14. Singapore consumer inflation remains steady at 1.2% in November, missing estimates

15. How Build-A-Bear went from a penny stock to a retail winner

16. Nike gets named a top pick at Jefferies — plus, what's next for Starbucks stock

17. Greenland PM rebukes Trump special envoy overture

18. The NBA is pursuing ownership groups for a potential basketball league in Europe

19. Denmark to summon U.S. ambassador as Trump's Greenland special envoy appointment stirs tensions

20. Paramount guarantees Larry Ellison backing in amended WBD bid